ACUTE NORMOVOLEMIC HEMODILUTION DECREASES BLOOD PRODUCT USE AND POSTOPERATIVE MORTALITY AND MORBIDITY FOLLOWING CARDIAC SURGERY  by Sarin, Eric et al.
Quality of Care and Outcomes Assessment
E1843
JACC March 27, 2012
Volume 59, Issue 13
ACUTE NORMOVOLEMIC HEMODILUTION DECREASES BLOOD PRODUCT USE AND POSTOPERATIVE 
MORTALITY AND MORBIDITY FOLLOWING CARDIAC SURGERY
ACC Moderated Poster Contributions
McCormick Place South, Hall A
Monday, March 26, 2012, 9:30 a.m.-10:30 a.m.
Session Title: Cost Effective Care
Abstract Category: 31. Quality of Care and Outcomes Assessment
Presentation Number: 1256-293
Authors: Eric Sarin, Alan Speir, Linda Henry, Sari Holmes, Sharon Hunt, Linda Halpin, Niv Ad, Inova Heart and Vascular Institution, Falls Church, VA, USA
Background: Acute Normovolemic Hemodilution (ANH) is an established technique with suggested efficacy in reducing transfusion requirements 
following cardiac surgery. The degree which ANH minimizes blood product usage and whether this impacts clinical outcomes remains controversial. 
Our purpose was to examine differences in blood product usage and morbidity and mortality related to ANH in cardiac surgical patients.
Methods: All non-isolated CABG patients since 2008(n=1,319) at a single center were studied. Data including blood product use, post-operative 
morbidity and mortality were retrieved from our local STS database. ANH was performed using standard autologous blood collection bags and stored 
at room temperature. Total volume collected was based on predicted on-pump hematocrit. Multivariate analyses were conducted to evaluate the 
role of ANH on risk for blood product use after controlling for multiple confounding variables including, age, gender, preoperative hematocrit, and 
elective status.
Results: The ANH group had fewer comorbidities compared to the no ANH group. The ANH group received significantly fewer units of blood products 
(PRBC’s, FFP, Cryo and Platelets) than the no ANH group (p <0.001). After adjusting for clinical covariates, ANH was associated with reduced risk for 
intraoperative blood product use (OR=0.41, p<0.001), including RBC (OR=0.32, p<0.001) and FFP use (OR=0.49, p<0.001), Intraoperative RBC & 
FFP transfusion were independently associated with greater risk for prolonged ventilation (p<0.001 & p=0.003) and operative mortality (p=0.005 & 
p=0.04).
Conclusions: ANH patients received fewer intraoperative blood products regardless of the type of surgery. Furthermore, this decreased blood 
product exposure manifested decreased ventilator time and post-operative mortality. ANH should be considered as a valuable adjunct to current 
blood conservation techniques to minimize blood product exposure, reduce complication risk, and improve outcomes.
